沙库巴曲缬沙坦治疗老年慢性心功能不全的疗效及机制研究

doi:10.3969/j.issn.1003-9198.2021.08.012

摘要/Abstract

摘要： 目的分析沙库巴曲缬沙坦治疗老年慢性心功能不全的疗效及对病人心功能,血清心肌营养素-1(CT-1)、 β-内啡肽(β-EP)水平的影响。方法将我院2019年4月至2020年6月间收治的100例慢性心功能不全病人随机分为观察组和对照组,每组50例。对照组采用常规方案进行治疗,观察组在对照组基础上给予沙库巴曲缬沙坦钠片,观察并评估2组疗效。治疗前后检测并比较病人的心功能指标、6 min步行距离(6MWD)、明尼苏达心力衰竭生活质量问卷(MLHFQ)评分及血清中CT-1、 β-EP水平。结果观察组临床总有效率明显高于对照组(94.0% 比74.0%),差异有统计学意义(P<0.05)。治疗后,2组LVEF、每搏心输出量(SV)、6MWD 和CT-1水平明显高于治疗前,左心室舒张末内径(LVEDD)、MLHFQ评分和β-EP水平明显低于治疗前,且观察组改善更明显,差异均有统计学意义(P<0.01)。结论沙库巴曲缬沙坦治疗老年慢性心功能不全病人可有效提高临床疗效,并改善病人心功能和血清中CT-1、 β-EP水平。

关键词: 沙库巴曲缬沙坦, 慢性心功能不全, 心功能, 心肌营养素-1, β-内啡肽

Abstract: Objective To analyze the efficacy of sacubitril valsartan in the treatment of elderly patients with chronic heart failure and the influence on the heart function, serum levels of cardiotrophin-1(CT-1) and β-endorphin(β-EP). Methods A total of 100 patients with chronic heart failure in our hospital from April 2019 to June 2020 were randomly divided into the observation group and the control group,with 50 cases in each group. The control group was treated with conventional treatment, and the observation group was given sacubitril valsartan sodium tablets on the basis of the control group. The curative effect of the two groups was observed and evaluated. The heart function indexes, 6-minute walking distance (6MWD), Minnesota Living with Heart Failure Questionaire (MLHFQ) score, the serum levels of CT-1 and β-EP before and after the treatment were detected and compared. Results The clinical effective rate of the observation group was significantly higher than that of the control group (94.0% vs 74.0%, P<0.05). After treatment, the levels of left ventricular ejection fraction (LVEF), stroke volume (SV), 6MWD and CT-1 were significantly higher and the levels of left ventricular end-diastolic dimension (LVEDD),β-EP score and MLHFQ score were significantly lower in two groups than those before treatment, especially in the observation group (P<0.01). Conclusions Sacubitril valsartan can effectively improve the clinical efficacy, cardiac function and serum levels of CT-1 and β -EP of the elderly patients with chronic heart failure.

Key words: sacubatro valsartan, chronic heart failure, cardiac function, cardiotrophin-1, β-endorphin

中图分类号:

R 541.61

秦少强, 张占帅, 石金铮, 刘俊峰, 李卓然, 赵韩婷, 王亚玲, 李方江. 沙库巴曲缬沙坦治疗老年慢性心功能不全的疗效及机制研究[J]. 实用老年医学, 2021, 35(8): 837-839.

QIN Shao-qiang, ZHANG Zhan-shuai, SHI Jin-zheng, LI Zhuo-ran, ZHAO Han-ting, WANG Ya-ling, LI Fang-jiang. Study on the efficacy and mechanism of sacubitril valsartan in the treatment of elderly patients with chronic heart failure[J]. Practical Geriatrics, 2021, 35(8): 837-839.

参考文献

[1] COSENTINO E R, DEGLI E D, MICELI R, et al. Sacubitril/valsartan improves both functional and echocardiographic parameters in patients with chronic heart failure with reduced ejection fraction[J]. Curr Med Res Opin, 2019, 35(1): 9-12.
[2] BENNASAR M, TORRES X, CRISPI F, et al. EP09.01: Cardiac function in uncomplicated monochorionic diamniotic twins: comparison to singletons[J]. Ultrasound Obst Gyn, 2019, 54(S1): 286-286.
[3] 张一峰, 李树仁, 刘肖, 等. 未伴心力衰竭的非ST段抬高型心肌梗死病人院内急性左心衰竭的影响因素研究[J]. 实用心脑肺血管病杂志, 2019, 27(1): 33-37.
[4] PEREIRA D A G, FURTADO S R C, AMNCIO G P, et al. Association between heel-rise test performance and clinical severity of chronic venous insufficiency[J]. Phlebology, 2020, 35(8): 487.
[5] TIWARY S K, KUMAR P K, DHAMEEJA N, et al. Assessment and grading of pigmentation in chronic venous insufficiency[J]. Phlebology, 2019, 35(6): 547.
[6] 陈蕊, 赵阳, 费家玥, 等. 老年射血分数保留心力衰竭病人心肺运动试验特点及中间片段心房利钠肽原临床价值的研究[J]. 中华老年医学杂志, 2020, 39(7): 770-773.
[7] BROWN L, LUCIANO A, PENDERGAST J, et al. Predictors of net acid excretion in the Chronic Renal Insufficiency Cohort (CRIC) Study[J]. Am J Kidney Dis, 2019, 74(2): 203-212.
[8] HARRISON J C, SMART S D G, BESLEY E M H, et al. A clinically relevant functional model of type-2 cardio-renal syndrome with paraventricular changes consequent to chronic ischaemic heart failure[J]. Sci Rep, 2020, 10(1): 1261.
[9] LAMPREAM J A, ZELNICK L R, SHLIPAK M G, et al. Cardiac biomarkers and risk of atrial fibrillation in chronic kidney disease: The CRIC Study[J]. J Am Heart Assoc, 2019, 8(15): e012200.
[10] MENEZ S, PARIKH C R. Renin-angiotensin system blockade after acute kidney injury: the plot thickens[J]. Clin J Am Soc Nephro, 2019, 15(1): 2-4.
[11] 郑丽, 张亚同, 张卫娜, 等. 沙库巴曲缬沙坦钠对比血管紧张素转换酶抑制剂/血管紧张素Ⅱ受体拮抗剂治疗心力衰竭的安全性和有效性的荟萃分析[J]. 中国心血管杂志, 2020, 25(6): 575-580.
[12] NISHA B, LEILA Z. Cardiac biomarkers and risk of incident heart failure in chronic kidney disease: The CRIC (Chronic Renal Insufficiency Cohort) Study[J]. J Am Heart Assoc, 2019, 8(21): e012336.

[1]	朱蓓, 杭乐佳, 高飞, 袁海川, 赵卫红. 老年血液透析病人衰弱与血清瘦素及25-羟维生素D的相关性研究[J]. 实用老年医学, 2024, 38(6): 603-606.
[2]	刘瑾, 黄艳秋, 朱毅, 卓莉莉. 沙库巴曲缬沙坦钠对老年慢性心力衰竭病人的影响[J]. 实用老年医学, 2024, 38(10): 1030-1033.
[3]	白晓瑜, 张君, 赵鹏, 魏梅, 邱亚辉, 冯雪娟. 5次坐立试验与老年PCI病人心功能及生活质量的相关性研究[J]. 实用老年医学, 2023, 37(8): 777-780.
[4]	胡静雯, 姜婉莹, 霍俊宇, 王岚, 王骁智. 中低剂量沙库巴曲缬沙坦对射血分数降低的老年心力衰竭病人心室重构和再住院率的影响[J]. 实用老年医学, 2023, 37(8): 828-833.
[5]	佀思聪, 杨伟, 王洁妤, 罗鸿宇, 马艺欣, 赵欢. 老年2型糖尿病病人血糖变异情况以及平均血糖波动幅度与心功能的相关性[J]. 实用老年医学, 2023, 37(4): 361-364.
[6]	李善淑, 吕逸宁, 宫慧敏, 张改改. 沙库巴曲缬沙坦治疗老年慢性心力衰竭病人效果的Meta分析[J]. 实用老年医学, 2023, 37(10): 1023-1026.
[7]	罗特丹, 周冲冲, 黄鹤鸣. 肠内营养联合双歧杆菌三联活菌对老年慢性心力衰竭病人心功能及微炎症状态的影响[J]. 实用老年医学, 2022, 36(9): 883-887.
[8]	杨澄, 孙晓静, 张振英, 张柳, 许志萍, 王立中. 负荷深呼吸康复训练对老年慢性阻塞性肺疾病缓解期病人心肺功能及生活质量的影响[J]. 实用老年医学, 2022, 36(7): 715-719.
[9]	权乾坤, 冯建军, 李玺, 李婉妮, 张秀丽, 刘春田. 重组人脑利钠肽、沙库巴曲缬沙坦、托伐普坦序贯治疗高龄射血分数降低的心力衰竭病人的疗效观察[J]. 实用老年医学, 2021, 35(9): 957-961.
[10]	陈萍, 杨明, 韩凌, 陈欣, 胡文泽, 李晓红. 右心室流出道间隔部和心尖部起搏对老年患者心功能的影响[J]. 实用老年医学, 2016, 30(2): 142-.
[11]	王文娟, 蔡江涛, 白梅. 超声心动图评估老年心肌梗死后心力衰竭患者右心功能的临床价值[J]. 实用老年医学, 2016, 30(1): 65-.
[12]	张瑞英, 杨栓锁, 郑文权, 乔增勇. 老年慢性充血性心力衰竭患者血清炎性因子水平变化及其与心功能之间的关系研究[J]. 实用老年医学, 2015, 29(9): 731-.
[13]	罗经宏. 氢氯噻嗪联合制剂对心肌梗死后心衰大鼠心功能及心肌纤维化的影响[J]. 实用老年医学, 2015, 29(8): 682-.
[14]	樊留芳, 殷泉忠, 崔俊友, 马捷敏. 阿托伐他汀对老年慢性心力衰竭患者心功能和相关炎症因子的影响[J]. 实用老年医学, 2015, 29(12): 1014-.
[15]	余鹏, 涂飞, 张霞, 钱波, 刘莉. 热休克蛋白27心肌特异性高表达诱导小鼠产生心肌肥厚[J]. 实用老年医学, 2014, 28(6): 506-.